A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients
Clinical trial NCT04916756 · COMPLETED
Trial details
- NCT number
- NCT04916756
- Sponsor
- Peking Union Medical College Hospital
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-16
- Primary completion
- 2020-12-24
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.